Africa Malaria Treatment Market is growing with factors such as the increased prevalence of malaria diseases, humid climatic conditions, and rising number of mosquitoes (Anopheles Gambiae Complex) in certain parts of Africa, and the strategic initiatives taken by market players.
However, the stringent government regulation may obstruct the growth of the market in the given forecast period.
Africa Malaria Treatment Market Scenario
According to Data Bridge Market Research, the market in Africa region has the highest market share. The market leader is Novartis AG which accounts for an estimated market share of approximately 13.35%. The company has gained outstanding sales through providing malaria treatment to all the countries and rapid product approvals.
- In March 2020, Novartis AG donated doses of antimalarial drug hydroxychloroquine to treat several million patients fighting against the coronavirus. As hydroxychloroquine, an antimalarial drug utilized in the treatment of COVID-19, it is expected that this donation is anticipated to accelerate the market position of the company
Trends Impacting the Market
Now the question is which other regions Novartis AG, Hikma Pharmaceuticals PLC, and Cipla Inc., are targeting? Data Bridge Market Research has estimated a large growth in the Africa malaria treatment market. The market leaders target Nigeria, Democratic Republic of the Congo, and Uganda to be their next revenue pockets for 2021.
The Africa malaria treatment market is becoming more competitive with Novartis AG, Cipla Inc., Hikma Pharmaceuticals PLC. They are the market leaders for the Africa malaria treatment market. The data bridge market research new reports highlight the major growth factors and opportunities in the Africa malaria treatment market.
For more analysis on the Africa malaria treatment market, request a briefing with our analysts https://www.databridgemarketresearch.com/jp/speak-to-analyst/?dbmr=africa-malaria-treatment-market
Africa Malaria Treatment Market Development
- In December 2017, World Health Organization prequalified artemether/lumefantrine dispersible tablet by Strides Pharma Science Limited. The prequalification has bolstered further development study as well as elevated the company's position in the market
Scope of the Africa Malaria Treatment Market
The Africa malaria treatment market is segmented based on Nigeria, the Democratic Republic of the Congo, Uganda, Niger, Côte d’Ivoire, Kenya, South Africa, Egypt, and the Rest of Africa.
All country-based analysis of the Africa malaria treatment market is further analyzed based on further segmentation. The Africa malaria treatment market is categorized into seven notable segments based on agent, type, treatment type, drug type, route of administration, end user, and distribution channel.
- On the basis of agent, the Africa malaria treatment market is segmented into Plasmodium Falciparum, P. Vivax, P. Ovale, P. Malariae, and P. Knowlelsi. On the basis of type, the Africa malaria treatment market is segmented into medication, vaccination, and others. On the basis of treatment type, the Africa malaria treatment market is segmented into suppressive treatment and radical treatment. On the basis of drug type, the Africa malaria treatment market is segmented into branded and generics. On the basis of route of administration, the Africa malaria treatment market is segmented into oral and parenteral. On the basis of end user, the Africa malaria treatment market is segmented into hospitals, specialty clinics, home healthcare, and others. On the basis of distribution channel, the Africa malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others.
To know more about the study https://www.databridgemarketresearch.com/jp/reports/africa-malaria-treatment-market
Key Pointers Covered in Africa Malaria Treatment Market Industry Trends and Forecast to 2028
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
Key Market Competitors Covered in the Report
- Hikma Pharmaceuticals PLC
- Sun Pharmaceutical Industries Ltd.
- Zydus Cadila
- Cipla Inc.
- GlaxoSmithKline plc.
- Bliss GVS Pharma Ltd.
- MMV
- Novartis AG
- Taj Pharmaceuticals Limited
- Lupin Pharmaceuticals, Inc. (A Subsidiary of Lupin Limited)
- AJANTA PHARMA
- Strides Pharma Science Limited
- sanofi-aventis U.S. LLC (A Subsidiary of Sanofi)
- Viatris Inc.
Above are the key players covered in the report. To know about more and exhaustive list of Africa malaria treatment market companies’, contact us https://www.databridgemarketresearch.com/jp/toc/?dbmr=africa-malaria-treatment-market
Research Methodology: Africa Malaria Treatment Market.
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or can drop down your inquiry.
The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis.
Primary Respondents
- Demand Side: Manufacturer, Geneticists, Healthcare Industry, Scientists, Research Laboratories
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers, among others.
Related Reports
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/jp/report-category/healthcare/
